Cham­ber of Com­merce looks to halt drug price ne­go­ti­a­tions be­fore they be­gin

With all eyes on sev­er­al pend­ing law­suits over CMS’ new drug price-set­ting abil­i­ties, the US Cham­ber of Com­merce yes­ter­day took its suit one step fur­ther, call­ing on an Ohio dis­trict court to halt CMS’ on­go­ing process­es while the lit­i­ga­tion plays out.

The law­suit comes less than two months be­fore CMS is ex­pect­ed to an­nounce the first 10 drugs that will have to sub­mit to the ne­go­ti­a­tion process or face steep penal­ties.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER